News

In addition to ChatGPT for Clinicians, OpenAI introduced ChatGPT for Healthcare earlier this year.

Findings indicate that care within guide dog partnerships is relational and dynamic, with both dog and handler alternately giving and receiving care.

Giannie Castellanos, OD, calls on optometrists to empower others in the field and refer within their specialty.

The study was conducted by researchers from VisionSpring and Queen’s University Belfast, with support from USAID.

An ophthalmology resident reflects on the risky business of tap water–rinsed contacts and cases.

Jessica Crooker, OD, highlights how physicians can identify early signs of menopause in the eye and debunk misconceptions about presbyopia for women.

What to know about the current state of artificial intelligence and multimodal retinal imaging in systemic disease surveillance in eye care.

The company has collected and recycled 119,715,074 units, or 724,922 pounds, of used contact lenses and eye care materials in the US.

A global systemic review recently found that women had less access to glasses than men in low- to middle-income regions.

Myopia management is not one-size-fits-all, writes Magdalena Stec, OD, FAAO.

Noelle Whitestone, MHA, discusses the implications of findings from a recent Orbis International study.

BostonSight SCLERAL now offers a complete diameter range from 14.5mm to 19.0mm.

Gianne Castellanos, OD, shares the care limitations optometric practice owners face and trends in ophthalmic practice that she has uncovered in part of her research.

At 12 weeks, improvements in visual and anatomical outcomes were observed across all groups.

CMS assigns billing code to support reimbursement for the keratoconus therapy.

All 3 concentrations evaluated in the study were associated with reduced myopia progression.

Data from a recent trial of the OmniVu Lens System was presented at ASCRS 2026, featuring positive and sustained vision end points.

The launch is supported by results from a phase 3 randomized, double-masked, placebo-controlled trial (3-02).

The analysis included 12,183,254 patients, with 304,823 identified as smokers and 11,878,431 as non-smokers.

The trial is evaluating AURN001, a single-administration regenerative cell therapy for corneal edema secondary to corneal endothelial dysfunction.

The analysis included studies 31 studies identified through Web of Science, PubMed, CNKI, and Wanfang databases through October 2025.

Kevin J. Kovach, MD, said that patient education as a part of the referral process can both improve care and comanagement relationships.

The decision lengthens the approved treatment period outlined in the prescribing information and may lessen the need to change therapies for patients who continue to show a lasting response.

Mt. Sinai introduced the miDOC system at the ASCRS annual meeting.

Several presentations at ASCRS 2026 spotlight faster dry eye relief and smarter pre-operative care, showing lifitegrast and new drugs can ease symptoms quickly and improve cataract biometry.

Expanded guidance incorporates advanced diagnostics and reinforces treatment of conditions such as Demodex blepharitis and neuropathic pain, explains Christopher E. Starr, MD, FACS.

The TECNIS Eyhance IOL is part of the TECNIS platform, which Johnson & Johnson said has been used in ophthalmology for more than 25 years.